ENTRY       D00514                      Drug
NAME        Dexmedetomidine (USAN/INN);
            Dexdor (TN);
            Precedex (TN)
FORMULA     C13H16N2
EXACT_MASS  200.1313
MOL_WEIGHT  200.2795
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01449  alpha2-Adrenergic receptor agonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01638  CYP2A6 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG02855  CYP2E1 substrate
REMARK      Same as: C07450
            ATC code: N05CM18
            Chemical structure group: DG00926
            Product (DG00926): D01205<JP/US>
EFFICACY    Sedative-hypnotic, Tranquilizer, alpha2-Adrenergic receptor agonist
TARGET      ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP2A6 [HSA:1548]; CYP1A2 [HSA:1544], CYP2E1 [HSA:1571], CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CM Other hypnotics and sedatives
                 N05CM18 Dexmedetomidine
                  D00514  Dexmedetomidine (USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00926  Dexmedetomidine
                  D00514  Dexmedetomidine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00926  Dexmedetomidine
                D00514  Dexmedetomidine
              DG01638  CYP2A6 substrate
               DG00926  Dexmedetomidine
                D00514  Dexmedetomidine
              DG01639  CYP2C19 substrate
               DG00926  Dexmedetomidine
                D00514  Dexmedetomidine
              DG01644  CYP2D6 substrate
               DG00926  Dexmedetomidine
                D00514  Dexmedetomidine
              DG02855  CYP2E1 substrate
               DG00926  Dexmedetomidine
                D00514  Dexmedetomidine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2
                 D00514  Dexmedetomidine (USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00514
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00514
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00926  Dexmedetomidine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00926  Dexmedetomidine
              DG01638  CYP2A6 substrate
               DG00926  Dexmedetomidine
              DG01639  CYP2C19 substrate
               DG00926  Dexmedetomidine
              DG01644  CYP2D6 substrate
               DG00926  Dexmedetomidine
              DG02855  CYP2E1 substrate
               DG00926  Dexmedetomidine
DBLINKS     CAS: 113775-47-6
            PubChem: 7847580
            ChEBI: 4466
            PDB-CCD: CZX
            LigandBox: D00514
            NIKKAJI: J263.999H
ATOM        15
            1   C8y C    21.8688  -21.7213
            2   C1c C    23.0601  -20.9504
            3   C8y C    20.6775  -20.9504
            4   C8x C    21.8688  -23.0527
            5   C8y C    24.3214  -21.7213
            6   C1a C    23.0601  -19.5490
            7   C8y C    19.4162  -21.7213
            8   C1a C    20.6075  -19.5490
            9   C8x C    20.6775  -23.7534
            10  C8x C    24.3214  -23.1228
            11  N5x N    25.5828  -21.2307
            12  C8x C    19.4162  -23.1228
            13  C1a C    18.2249  -21.0205
            14  N4x N    25.6528  -23.4731
            15  C8x C    26.4236  -22.3519
BOND        16
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Down
            6     3   7 1
            7     3   8 1
            8     4   9 2
            9     5  10 2
            10    5  11 1
            11    7  12 2
            12    7  13 1
            13   10  14 1
            14   11  15 2
            15    9  12 1
            16   14  15 1
///
